IRIS Institutional Research Information System - OPENBS Open Archive UniBS

Pagnesi, Matteo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.087
NA - Nord America 1.457
EU - Europa 866
SA - Sud America 684
AF - Africa 51
OC - Oceania 4
Totale 5.149
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.384
SG - Singapore 827
BR - Brasile 582
CN - Cina 417
HK - Hong Kong 380
IT - Italia 243
VN - Vietnam 179
DE - Germania 153
RU - Federazione Russa 94
GB - Regno Unito 91
TR - Turchia 91
FI - Finlandia 68
FR - Francia 37
AR - Argentina 34
BD - Bangladesh 34
CA - Canada 34
PL - Polonia 33
IN - India 31
JP - Giappone 27
MX - Messico 26
IE - Irlanda 25
ZA - Sudafrica 24
AT - Austria 21
NL - Olanda 21
UA - Ucraina 20
ES - Italia 17
EC - Ecuador 16
SA - Arabia Saudita 16
IQ - Iraq 15
CO - Colombia 14
ID - Indonesia 14
PY - Paraguay 10
SE - Svezia 10
VE - Venezuela 10
CZ - Repubblica Ceca 9
AE - Emirati Arabi Uniti 8
EG - Egitto 8
MA - Marocco 8
PE - Perù 7
CL - Cile 6
TN - Tunisia 6
UZ - Uzbekistan 6
AZ - Azerbaigian 5
LT - Lituania 5
PK - Pakistan 5
OM - Oman 4
PA - Panama 4
BO - Bolivia 3
IL - Israele 3
IR - Iran 3
JM - Giamaica 3
KE - Kenya 3
KZ - Kazakistan 3
LV - Lettonia 3
PS - Palestinian Territory 3
AL - Albania 2
AU - Australia 2
HN - Honduras 2
HU - Ungheria 2
JO - Giordania 2
KG - Kirghizistan 2
LK - Sri Lanka 2
NP - Nepal 2
NZ - Nuova Zelanda 2
UY - Uruguay 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
IS - Islanda 1
KH - Cambogia 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
NO - Norvegia 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 5.149
Salva come PNG Salva come JPEG
Città #
Hong Kong 377
Singapore 367
Beijing 179
Ashburn 169
Los Angeles 103
New York 90
Ho Chi Minh City 76
Istanbul 74
Chandler 67
Dallas 63
The Dalles 63
Munich 56
Redondo Beach 54
São Paulo 49
Moscow 46
Romola 44
Chicago 42
Milan 38
San Francisco 36
Helsinki 35
Hanoi 33
Buffalo 30
London 26
Dublin 25
Tokyo 25
Princeton 24
Shanghai 22
Warsaw 22
Brooklyn 20
Frankfurt am Main 18
Montreal 18
Denver 16
Lappeenranta 16
Nuremberg 16
Boston 15
Poplar 15
Brescia 14
Santa Clara 14
Düsseldorf 13
Haiphong 13
Turku 13
Mexico City 12
Orem 12
Phoenix 12
Rome 12
Rio de Janeiro 11
Atlanta 10
Curitiba 10
Johannesburg 10
Stockholm 10
Vienna 10
Changsha 9
Charlotte 9
Manaus 9
Ribeirão Preto 9
Amsterdam 8
Ankara 8
Boardman 8
Brasília 8
Guangzhou 8
Quito 8
Riyadh 8
Tianjin 8
Biên Hòa 7
Thái Bình 7
Toronto 7
Asunción 6
Belo Horizonte 6
Brno 6
Campinas 6
City of London 6
Houston 6
Itajaí 6
Lima 6
Medellín 6
Querétaro 6
Ribeirão das Neves 6
Salvador 6
Strasbourg 6
Tashkent 6
West Jordan 6
Baku 5
Campina Grande 5
Chennai 5
Guarulhos 5
Guayaquil 5
Joinville 5
Manchester 5
Miami 5
Padova 5
Piracicaba 5
Portsmouth 5
Anápolis 4
Bauru 4
Berlin 4
Buenos Aires 4
Cairo 4
Cape Town 4
Caracas 4
Caxias do Sul 4
Totale 2.843
Salva come PNG Salva come JPEG
Nome #
Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study 84
Congestion in Patients with Advanced Heart Failure: Assessment and Treatment 83
2024 update in heart failure 81
Advanced heart failure: guideline-directed medical therapy, diuretics, inotropes, and palliative care 79
April 2021 at a glance: focus on systolic function, quality of life and treatment in heart failure 77
Vericiguat for Heart Failure with Reduced Ejection Fraction 76
Telemedicine for the treatment of heart failure: new opportunities after COVID-19 73
Medical therapy of cardiogenic shock: Contemporary use of inotropes and vasopressors 73
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 72
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 70
Clinical impact of changes in mitral regurgitation severity after medical therapy optimization in heart failure 70
Prognostic significance of serum potassium in patients hospitalized for acute heart failure 69
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study 66
Sodium glucose co-transporter 2 inhibitors and quality of life in patients with heart failure: a comprehensive systematic review and meta-analysis of randomized controlled trials 66
Cardiac contractility modulation: an effective treatment strategy for heart failure beyond reduced left ventricular ejection fraction? 65
High troponin levels in patients hospitalized for coronavirus disease 2019: a maker or a marker of prognosis? 65
Prognostic value of right ventricular longitudinal strain in patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge mitral valve repair 64
Clinical implications of left atrial changes after optimization of medical therapy in patients with heart failure 64
Combined pre- and post-capillary pulmonary hypertension in left heart disease 61
Characteristics and outcomes of patients with tricuspid regurgitation and advanced heart failure 60
Heart failure: an update from the last years and a look at the near future 60
Predictors of optimal procedural result after transcatheter edge-to-edge mitral valve repair in secondary mitral regurgitation 60
Evolution of tricuspid regurgitation after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation and its impact on mortality 60
Obesity, heart failure with preserved ejection fraction, and the role of glucagon-like peptide-1 receptor agonists 59
Impact of mitral regurgitation in patients with worsening heart failure: insights from BIOSTAT-CHF 59
Characteristics, treatment, and outcomes of early vs. late enrollees of the STRONG-HF trial 57
Transcatheter edge-to-edge mitral valve repair for post-myocardial infarction papillary muscle rupture and acute heart failure: A systematic review 56
Prognostic role of tricuspid annular plane systolic excursion/pulmonary artery systolic pressure ratio in patients hospitalized for acute heart failure 56
Predictors and Clinical Impact of Prosthesis-Patient Mismatch After Self-Expandable TAVR in Small Annuli 56
Right heart failure and mortality in patients undergoing transcatheter tricuspid valve interventions 55
Clinical Impact of Renal Dysfunction in Patients with Severe Tricuspid Regurgitation and Chronic Heart Failure 54
GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis 54
Frailty according to the 2019 HFA-ESC definition in patients at risk for advanced heart failure: Insights from the HELP-HF registry 54
Safety and Efficacy of Istaroxime 1.0 and 1.5 µg/kg/min for Patients with Pre Cardiogenic Shock 53
Impact of mitral regurgitation in patients with acute heart failure: insights from the RELAX-AHF-2 trial 53
Deep phenotype characterization of hypertensive response to exercise: implications on functional capacity and prognosis across the heart failure spectrum 53
Malnutrition and outcomes in patients with tricuspid regurgitation undergoing transcatheter tricuspid valve repair 53
Impact of malnutrition in patients with severe heart failure 52
Right ventricular thrombosis: from a case report to pathophysiology mechanisms and current treatment options 52
Ischemic Etiology in Advanced Heart Failure: Insight from the HELP-HF Registry 52
Clinical burden and predictors of non-cardiovascular mortality and morbidity in advanced heart failure 51
Medical therapy for heart failure with preserved ejection fraction: Still a minefield, but with new hope 50
Predicting survival in patients with severe heart failure: Risk score validation in the HELP-HF cohort 50
Treating amyloid transthyretin cardiomyopathy: lessons learned from clinical trials 49
Clinical and prognostic implications of heart failure hospitalization in patients with advanced heart failure 49
Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry 49
Multimodality imaging in the diagnostic management of concomitant aortic stenosis and transthyretin-related wild-type cardiac amyloidosis 49
Decongestion and Outcomes in Patients Hospitalized for Acute Heart Failure: Insights From the RELAX-AHF-2 Trial 49
Performance of risk stratification scores and role of comorbidities in older vs younger patients with pulmonary arterial hypertension 48
March 2021 at a glance: focus on epidemiology, prevention and COVID-19 48
Incidence, Predictors, and Prognostic Impact of New Permanent Pacemaker Implantation After TAVR With Self-Expanding Valves 48
Detailed Assessment of the "I Need Help" Criteria in Patients With Heart Failure: Insights From the HELP-HF Registry 47
Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM-AHF trial 47
Prediction of Mortality and Heart Failure Hospitalization After Transcatheter Tricuspid Valve Interventions: Validation of TRISCORE 47
Biologically active adrenomedullin as a marker for residual congestion and early rehospitalization in patients hospitalized for acute heart failure: Data from STRONG-HF 47
Sex differences in pulmonary arterial hypertension: Insights from the FOCUS-PAH registry 46
Epidemiology, pathophysiology, diagnosis and management of chronic right-sided heart failure and tricuspid regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC 45
Guideline-directed medical therapy in severe heart failure with reduced ejection fraction: an analysis from the HELP-HF registry 45
Ventilation strategies in cardiogenic shock: Insights from the AltShock-2 registry 45
Effects of omecamtiv mecarbil in heart failure with reduced ejection fraction according to blood pressure: the GALACTIC-HF trial 45
Blood pressure and intensive treatment up-titration after acute heart failure hospitalization: Insights from the STRONG-HF trial 45
Left atrial disease and left atrial reverse remodelling across different stages of heart failure development and progression: a new target for prevention and treatment 45
NT-proBNP and high-intensity care for acute heart failure: the STRONG-HF trial 44
February 2021 at a glance: focus on amyloidosis, myocarditis and cardiomyopathy 43
Burst steroid therapy and quality of life in patients with acute heart failure: Insights from the CORTAHF trial 43
Assessing aortic flow with doppler echocardiography in cardiogenic shock: A crucial diagnostic tool 43
Prognostic Benefit of New Drugs for HFrEF: A Systematic Review and Network Meta-Analysis 43
Optimization of Evidence-Based Heart Failure Medications After an Acute Heart Failure Admission: A Secondary Analysis of the STRONG-HF Randomized Clinical Trial 43
Changes in Liver Function Tests, Congestion, and Prognosis After Acute Heart Failure: The STRONG-HF Trial 43
Organ perfusion pressure predicts outcomes in cardiogenic shock patients 42
Effects of Rapid Uptitration of Neurohormonal Blockade on Effective, Sustainable Decongestion and Outcomes in STRONG-HF 41
Acute Heart Failure: Transitioning From Symptom-Based Care to Remission 41
Titration of Medications After Acute Heart Failure Is Safe, Tolerated, and Effective Regardless of Risk 41
Early changes in renal function during rapid up-titration of guideline-directed medical therapy following an admission for acute heart failure 40
Uptitrating Treatment After Heart Failure Hospitalization Across the Spectrum of Left Ventricular Ejection Fraction 40
Prognostic role of TAPSE to PASP ratio in outpatients with left ventricular systolic dysfunction 39
Characteristics, Prognosis and ESC/ERS Risk Stratification in Obese Patients with Pulmonary Arterial Hypertension (PAH) 38
Role of ejection fraction in patients at risk for advanced heart failure: insights from the HELP-HF registry 38
Differences between cardiogenic shock related to acute decompensated heart failure and acute myocardial infarction 38
Is it NICE to measure natriuretic peptides after a hospitalization for heart failure? 37
Functional Mitral Regurgitation and Heart Failure With Preserved Ejection Fraction: Clinical Implications and Management 37
Ejection fraction in heart failure: just become Emperor's new clothes? 37
Differential biomarker expression in heart failure patients with and without mitral regurgitation: Insights from BIOSTAT-CHF 37
Frequency, characteristics and risk assessment of pulmonary arterial hypertension with a left heart disease phenotype 36
Impact of SGLT2 inhibitors on endothelial function and echocardiographic parameters in dilated cardiomyopathy 36
Towards a phenotype profiling of the patients with heart failure and preserved ejection fraction 35
Socio-economic status and the effect of guideline-directed medical therapy in the STRONG-HF study 34
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure in elderly patients: a sub-analysis of the STRONG-HF randomized clinical trial 34
Impact of Rapid Up-Titration of Guideline-Directed Medical Therapies on Quality of Life: Insights From the STRONG-HF Trial 34
Noncardiac comorbidities and intensive up-titration of oral treatment in patients recently hospitalized for heart failure: insights from the STRONG-HF trial 33
Safety Indicators in Patients Receiving High-intensity Care After Hospital Admission for Acute Heart Failure: The STRONG-HF Trial 32
Effects of anti-inflammatory therapy in acute heart failure: a systematic review and meta-analysis 32
Intra-Aortic Balloon Pumping in Acute Decompensated Heart Failure With Hypoperfusion: From Pathophysiology to Clinical Practice 32
Mapping of current practices of palliative care for patients with heart failure throughout Europe: A scoping review 31
Lactate Values and Mortality in Patients With Cardiogenic Shock: Insights From the Altshock-2 Registry 31
Insights on prevalence and incidence of anemia and rapid up-titration of oral heart failure treatment from the STRONG-HF study 31
Reply to "Clinical implications of left atrial changes after optimization of medical therapy in heart failure patients" 30
Aetiological phenotypes of atrial and ventricular secondary tricuspid regurgitation and their prognostic implications: insights from the CARE-TR registry 29
Sex-specific analysis of the rapid up-titration of guideline-directed medical therapies after a hospitalization for acute heart failure: Insights from the STRONG-HF trial 29
Reply to 'Malnutrition and severe heart failure in real-world study settings' 28
Totale 4.965
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.113
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.113
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202236 0 0 0 0 2 1 2 0 2 0 3 26
2022/2023206 23 21 4 6 15 56 2 16 26 1 13 23
2023/2024622 27 11 52 33 30 71 42 17 150 21 43 125
2024/20251.864 13 22 81 152 144 140 203 94 161 225 370 259
2025/20262.512 440 595 355 677 411 34 0 0 0 0 0 0
Totale 5.240